by Judith Cassel | Feb 19, 2024 | News
New FDA Report Highlights How Marijuana Rescheduling Review Analyzed Cannabis Users’ Social Media Posts The Food and Drug Administration (FDA) is highlighting its scientific review into marijuana that led the agency to recommend rescheduling—a process that involved a...
by Judith Cassel | Feb 19, 2024 | News
The New Mexico Senate has unanimously approved a bipartisan resolution requesting that state officials research the therapeutic potential of psilocybin and explore the creation of a regulatory framework to provide access to the psychedelic. The body voted 37-0 to pass...
by Judith Cassel | Jan 30, 2024 | News
Plaintiff Justyna Jensen brings this action against defendants Maryland Cannabis Administration (“MCA”) and William Tilburg (together, “Defendants”). Plaintiff sues Defendants over Defendants’ unconstitutional application program for adult use retail dispensary...
by Judith Cassel | Jan 22, 2024 | News
Medical Marijuana List[54 Pa.B. 315] [Saturday, January 20, 2024] Under the Medical Marijuana Act (act) (35 P.S. §§ 10231.101—10231.2110), the Pennsylvania State Ethics Commission (Commission) shall biennially publish a list of all State, county, municipal and other...
by Judith Cassel | Jan 17, 2024 | Blog
Based in part on its medical marijuana act, in November 2020, Oregon voters approved the use of psilocybin. Oregon voters passed Ballot Measure 109 titled the “Oregon Psilocybin Services Act”. Measure 109 is now codified in statute as ORS 475A. ORS 475A allows for...
717-703-0804
